Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post–2016 CDC Guideline

This retrospective cohort study examines changes in opioid prescribing patterns and health outcomes among patients with sickle cell disease before and after the release of the 2016 US Centers for Disease Control and Prevention (CDC) opioid.

from JAMA Internal Medicine Online First https://ift.tt/gtbPpHm